Clinic
Crestwood Healthcare LP
Crestwood Healthcare LP was paid $2.39M by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoCRESTWOOD HEALTHCARE LP
HUNTSVILLE, AL 35801
HUNTSVILLE, AL 35801
33aNPI1023061496assigned 05/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$2.39M
24GClaims114,231
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Alabama
Rank by total paid#2 of 33
Median peer was paid$7K
This provider vs. median349×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,639 | $402K | |
| 2019 | 22,456 | $407K | |
| 2020 | 12,664 | $258K | |
| 2021 | 13,512 | $262K | |
| 2022 | 14,797 | $313K | |
| 2023 | 17,009 | $455K | |
| 2024incomplete | 10,154 | $291K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 14,861 | 13,680 | $880K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 18,834 | 17,374 | $670K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 5.6% | 561 | 542 | $134K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.3% | 16,617 | 15,240 | $127K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.0% | 13,822 | 12,649 | $119K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 474 | 433 | $89K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,626 | 1,514 | $53K |
| 81001 | 1.4% | 9,705 | 8,906 | $33K | |
| 80076 | 1.3% | 5,628 | 5,205 | $32K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 2,806 | 2,334 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 416 | 373 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 753 | 665 | $26K |
46 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,476 | $19K |
| 87070 | <1% | 1,663 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,586 | $14K |
| 83690 | <1% | 2,388 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,543 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,212 | $11K |
| 82150 | <1% | 1,762 | $10K | |
| 84484 | <1% | 1,260 | $10K | |
| 84703 | <1% | 1,224 | $7K | |
| 74022 | <1% | 407 | $7K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 41 | $6K |
| 82553 | <1% | 528 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,668 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 535 | $4K |
| 87428 | <1% | 54 | $3K | |
| 82550 | <1% | 547 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 202 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 40 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 46 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 127 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,094 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 201 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 391 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 42 | $2K |
| 0240U | <1% | 1,217 | $1K | |
| 83655 | <1% | 58 | $975.56 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $785.68 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $700.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 75 | $647.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 693 | $574.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,030 | $392.05 |
| 85610 | <1% | 98 | $300.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $223.08 |
| 72100 | <1% | 17 | $219.23 | |
| 83735 | <1% | 27 | $191.26 | |
| 85730 | <1% | 82 | $128.48 | |
| 59025 | Fetal non-stress test | <1% | 21 | $80.40 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 24 | $76.82 |
| 87210 | <1% | 15 | $60.50 | |
| 86592 | <1% | 20 | $54.54 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 16 | $43.04 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 29 | $23.77 |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 0% | 54 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 302 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 236 | $0.00 |
| 82962 | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.